Tuesday, June 2, 2020

Mucopolysaccharidoses (MPS) Research

Mucopolysaccharidoses (MPS) research looks at the group of slowly progressive and inherited metabolic diseases which can effect skeletal structure, connective tissue, and organs of sufferers.

Mucopolysaccharidoses (MPS) is a rare disease caused by a genetic defect of certain enzymes that the body needs to break down molecules called glycosaminoglycans, long chains of sugars (carbohydrates) in each of our cells.

Health Europa brings you the latest mucopolysaccharidoses (MPS) research news from organisations such as MPS Austria, a non-profit-orientated charitable organisation run by Michaela Weigl since 1999. MPS Austria aims to promote awareness of research into MPS through information materials.

MPS Research News

Promising clinical research could revolutionise mucopolysaccharidosis treatment

Promising clinical research could revolutionise mucopolysaccharidosis treatment

According to research, mucopolysaccharidosis treatment is still emerging, but recent drug approval & promising clinical research studies could accelerate treatment pattern for those suffering. Mucopolysaccharidosis...
Exploring mucopolysaccharide storage disorders

Exploring mucopolysaccharide storage disorders

Susanne Gerit Kircher, Medical University of Vienna, argues that Europe must renew its efforts to tackle rare diseases such as mucopolysaccharide storage disorders. Mucopolysaccharide storage...
Becoming reality – mucopolysaccharide storage diseases and adulthood

Becoming reality – mucopolysaccharide storage diseases and adulthood

Susanne Gerit Kircher, of the Medical University of Vienna, explains why more resources and effort must be put into understanding mucopolysaccharide storage diseases in...
Mucopolysaccharide storage diseases and puberty and adolescence

Mucopolysaccharide storage diseases and puberty and adolescence

The Medical University of Vienna’s Susanne Gerit Kircher reflects on the medical progress that has allowed people affected by mucopolysaccharide storage diseases to start...

MPS Special Reports

MPS Therapy

Everything you need to know about the annual MPS therapy week

From 11 July to 20 July 2019, the annual MPS therapy week and bi-annual MPS Conference was hosted in Hinterglemm, in the South-East of...

Latest MPS eBooks

Introducing the Narrenturm: the world’s first hospital for the mentally ill

Before the end of the 18th century, those who were mentally ill were not regarded as patients, however in 1784 Austria, the Narrenturm was...

Living with mucopolysaccharidoses: support, awareness and research

Mucopolysaccharidoses (MPS) is a group of rare, inherited, incurable metabolic diseases caused by disorders in the metabolism, in this eBook the Austrian MPS Society...

Understanding mucopolysaccharide storage diseases

What are mucopolysaccharide storage diseases? What are their signs and symptoms? And what treatment options are available for patients? These are just some of the...

MPS Research News cont'd

The Fool’s Tower: Europe’s oldest building that accommodated mental patients

The Fool’s Tower: Europe’s oldest accommodation for mental patients

Health Europa explores with those involved in managing and expanding the then-hospital for mental patients, Vienna’s Narrenturm (Fool’s Tower). In September, Health Europa travelled to...
The Swiss perspective on mucopolysaccharide disease

The Swiss perspective on mucopolysaccharide disease

Dr Fredi Wiesbauer, vice president of the Swiss Mucopolysaccharide disease (MPS) Society met with Health Europa and explored the Swiss experience of hosting such...
The Austrian MPS Society’s Therapy Week – more than just therapy

The Austrian MPS Society’s Therapy Week – more than just therapy

In July, Health Europa saw first-hand how the Austrian MPS Society’s Therapy Week brings patients and their families together for more than just a...

Pin It on Pinterest